Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease

European Journal of Vascular and Endovascular Surgery

Volumn 42, Issue 6, 2011, Pages 817-823

  Sartori, M ^a   Conti, E ^a   Favaretto, E ^a   Frascaro, M ^a   Legnani, C ^a   Palareti, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Fibrinogen; FVIII; G20210A prothrombin; Homocysteine; LAC; Percutaneous transluminal angioplasty; Peripheral arterial disease; R506Q FV Leiden; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; HOMOCYSTEINE; LUPUS ANTICOAGULANT; PROTHROMBIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLAUDICATION; DIABETES MELLITUS; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; LIMB ISCHEMIA; MAJOR ADVERSE CARDIOVASCULAR EVENT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; THROMBOPHILIA; THROMBOSIS;

AGED; ANGIOPLASTY; CARDIOVASCULAR DISEASES; FACTOR V; FACTOR VIII; FEMALE; FIBRINOGEN; HOMOCYSTEINE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; LUPUS COAGULATION INHIBITOR; MALE; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STENTS; THROMBOPHILIA; THROMBOSIS;

EID: 81755166320     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.08.016     Document Type: Article

References (34)

1. G.M. Andreozzi, E. Arosio, R. Martini, F. Verlato, and A. Vison Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition Int Angiol 27 2008 93 113
2. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes TASC II Working Group Inter-society consensus for the management of peripheral arterial disease Int Angiol 26 2007 81 157
3. J.P. van Kuijk, W.J. Flu, G.M. Welten, S.E. Hoeks, M. Chonchol, and R. Vidakovic Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease Eur Heart J 31 2010 992 999
4. R. Hurks, W. Peeters, W.J. Derksen, W.E. Hellings, I.E. Hoefer, and F.L. Moll Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease Thromb Haemost 101 2009 48 54
5. D.M. Cohn, S. Roshani, and S. Middeldorp Thrombophilia and venous thromboembolism: implications for testing Sem Thromb Haemost 33 2007 573 581 (Pubitemid 47429309)
6. P.C. Bennett, S.H. Silverman, P.S. Gill, and G.Y. Lip Peripheral arterial disease and Virchow's triad Thromb Haemost 101 2009 1032 1040
7. M. Sartori, E. Favaretto, C. Legnani, M. Cini, E. Conti, and A. Amato Thrombophilic risk factors and peripheral arterial disease severity Thromb Haemost 104 2010 71 77
8. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines Circulation 113 2006 463 654
9. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adult (Adult Treatment Panel III). Final report Circulation 106 2002 3143 3421
10. M. Sartori, E. Favaretto, C. Legnani, M. Cini, E. Conti, and C. Pili G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease Eur J Vasc Endovasc Surg 38 2009 113 117
11. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerosis burden. Writing Group III Circulation 101 2000 16 22
12. C. Legnani, B. Cosmi, M. Cini, M. Frascaro, G. Guazzaloca, and G. Palareti High plasma levels of factor VIII and risk of recurrence of venous thromboembolism Br J Haematol 124 2004 504 510
13. F.B. Smith, A.J. Lee, C.M. Hau, A. Rumley, G.D. Lowe, and F.G. Fowkes Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study Blood Coagul Fibrinolysis 11 2000 43 50 (Pubitemid 30090903)
14. M.M. McDermott, D. Green, P. Greenland, K. Liu, M.H. Criqui, and C. Chan Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index Am J Cardiol 92 2003 194 199 (Pubitemid 36835970)
15. I. Tzoulaki, G.D. Murray, J.F. Price, F.B. Smith, A.J. Lee, and A. Rumley Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis Am J Epidemiol 163 2006 334 341 (Pubitemid 43238427)
16. M. Schillinger, M. Haumer, G. Schlerka, W. Mlekusch, M. Exner, and R. Ahmadi Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation J Endovasc Ther 5 2001 477 483 (Pubitemid 33032462)
17. M. Schillinger, M. Exner, W. Mlekusch, H. Rumpold, R. Ahmadi, and S. Sabeti Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis Radiology 225 2002 21 26
18. N. Khandanpour, Y.K. Loke, F.J. Meyer, B. Jennings, and M.P. Armon Homocysteine and peripheral arterial disease: systematic review and meta-analysis Eur J Vasc Endovasc Surg 38 2009 316 322
19. F. Sofi, B. Lari, A. Rogolino, R. Marcucci, G. Pratesi, and W. Dorigo Thrombophilic risk factors for symptomatic peripheral arterial disease J Vasc Surg 41 2005 255 260 (Pubitemid 40342476)
20. L.M. Taylor Jr. , R.D. DeFrang, E.J. Harris Jr. , and J.M. Porter The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease J Vasc Surg 13 1991 128 136
21. L.M. Taylor Jr. , G.L. Moneta, G.J. Sexton, R.A. Schuff, and J.M. Porter Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease J Vasc Surg 29 1999 8 19
22. V. Aboyans, M.H. Criqui, J.O. Denenberg, J.D. Knoke, P.M. Ridker, and A. Fronek Risk factors for progression of peripheral arterial disease in large and small vessels Circulation 113 2006 2623 2629 (Pubitemid 43948011)
23. T. Kovacevic, B. Van Der Loo, B.R. Amann-Vesti, V. Rousson, and R. Koppensteiner Plasma homocysteine and restenosis after femoropopliteal angioplasty J Endovasc Ther 11 2004 302 309 (Pubitemid 38802613)
24. D.A. Tsakiris, M. Tschöpl, K. Jäger, W.E. Haefeli, F. Wolf, and G.A. Marbet Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease Atherosclerosis 142 1999 193 200 (Pubitemid 28551825)
25. P.W. Kamphuisen, J.C. Eikenboom, and R.M. Bertina Elevated factor VIII levels and the risk of thrombosis Arterioscler Thromb Vasc Biol 21 2001 731 738 (Pubitemid 32448761)
26. L.M. Reich, G. Heiss, L.L. Boland, A.T. Hirsch, K. Wu, and A.R. Folsom Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort Vasc Med 12 2007 267 273
27. W. Lim, M.A. Crowther, and J.W. Eikelboom Management of antiphospholipid antibody syndrome: a systematic review JAMA 295 2006 1050 1057
28. B.R. Long, and F. Leya The role of antiphospholipid syndrome in cardiovascular disease Hematol Oncol Clin North Am 22 2008 79 94
29. L.J. Fligelstone, P.G. Cachia, H. Ralis, P. Whattling, R.H. Morgan, and A.A. Shandall Lupus anticoagulant in patients with peripheral vascular disease: A prospective study Eur J Vasc Endovasc Surg 9 1995 277 283
30. F. Puisieux, P. de Groote, E. Masy, C. Di Pompeo, A. Millaire, and O. Bouillanne Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease Am J Med 109 2000 635 641
31. E.Y. Lam, L.M. Taylor Jr. , G.J. Landry, J.M. Porter, and G.L. Moneta Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations J Vasc Surg 33 2001 976 982
32. V.E. Gerdes, H. ten Cate, E. de Groot, V.I. Kwa, M.H. Prins, and P.H. Reitsma Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis Atherosclerosis 163 2002 135 140 (Pubitemid 34615735)
33. A.V. Finn, M. Nakano, J. Narula, F.D. Kolodgie, and R. Virmani Concept of vulnerable/unstable plaque Arterioscler Thromb Vasc Biol 30 2010 1282 1292
34. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, and W. Insull Jr. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis Arterioscler Thromb Vasc Biol 15 1995 1512 1531